CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-10 | LUCAS ROGER C Director | Sale | −100 | $116.86 | $12K | 2,170 |
| 2017-07-09 | Gould Kevin S SVP Clinical Controls | Shares withheld for taxes | −312 | $117.68 | $37K | 1,355 |
| 2017-07-01 | Furlow Brenda S. SVP - General Counsel | Shares withheld for taxes | −278 | $117.50 | $33K | 1,668 |
| 2017-07-01 | Eansor Norman David SVP - Novus Biologicals | Shares withheld for taxes | −534 | $117.50 | $63K | 3,402 |
| 2017-06-09 | LUCAS ROGER C Director | Sale | −100 | $113.62 | $11K | 2,270 |
| 2017-05-31 | Dinarello Charles A Director | Sale | −5,000 | $111.37 | $557K | 7,473 |
| 2017-05-26 | Dinarello Charles A Director | Option exercise | +5,000 | $66.59 | $333K | 12,473 |
| 2017-05-26 | Dinarello Charles A Director | Option exercise · Stock Options (Right to buy) | −5,000 | 0 | ||
| 2017-05-25 | HOLBROOK KAREN A Director | Option exercise | +5,000 | $66.59 | $333K | 6,973 |
| 2017-05-25 | HOLBROOK KAREN A Director | Sale | −5,000 | $111.15 | $556K | 1,973 |
| 2017-05-25 | HOLBROOK KAREN A Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2017-05-22 | LUCAS ROGER C Director | Sale | −1,059 | $110.01 | $117K | 2,370 |
| 2017-05-10 | LUCAS ROGER C Director | Sale | −100 | $110.59 | $11K | 3,429 |
| 2017-04-10 | LUCAS ROGER C Director | Sale | −22 | $101.23 | $2K | 3,529 |
| 2017-04-10 | LUCAS ROGER C Director | Sale | −78 | $101.13 | $8K | 3,551 |
| 2017-03-31 | Hippel James Chief Financial Officer | Shares withheld for taxes | −800 | $101.65 | $81K | 3,079 |
| 2017-03-10 | LUCAS ROGER C Director | Sale | −79 | $107.76 | $9K | 3,650 |
| 2017-03-10 | LUCAS ROGER C Director | Sale | −21 | $107.81 | $2K | 3,629 |
| 2017-02-10 | LUCAS ROGER C Director | Sale | −100 | $102.60 | $10K | 3,729 |
| 2017-02-01 | Gavin Robert M. Senior V.P. Protein Platforms | Option exercise | +1,667 | 1,667 |
Page 59 of 64 · 1,274 trades